Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SUD Reprocessing Guidance Retains Premarket Exemptions For Now

This article was originally published in The Gray Sheet

Executive Summary

FDA has not yet decided whether it will retain premarket exemptions for reprocessed Class I/II single-use devices (SUDs), according to the Aug 2 final guidance "Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals."

You may also be interested in...



Device Data Systems Made Class I; Hospitals Could Face Regulation

FDA last week finalized a three-year-old proposal to down-classify Medical Device Data Systems to class I, or low-risk, medical devices exempt from pre-market review.

Device Data Systems Made Class I; Hospitals Could Face Regulation

FDA last week finalized a three-year-old proposal to down-classify Medical Device Data Systems to class I, or low-risk, medical devices exempt from pre-market review.

GHTF A Boon To Pre-Owned Capital Equipment Market – Commerce Dept.

The Global Harmonization Task Force's elevation of refurbished medical supply regulation issues "an important development" in lifting barriers for U.S. manufacturers exporting the devices, according to a Sept. 26 report by the U.S. Department of Commerce

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel